Upstream processes

Upstream-Downstream Integrated Intelligent Platform: Empowerment of Core Equipment in the Upstream Process (Fermentation and Preparation Stage)
2026-03-28
The core of the cell therapy upstream process is fermentation and preparation, whose core equipment directly determines downstream efficiency and product quality.Adopting an upstream‑downstream integrated strategy, Diwoxin has developed a high‑end intelligent platform that connects core fermentation equipment with downstream systems to maximize performance and drive the industrialization and standardization of upstream processes.
Integration of Synthetic Biology and Fermentation Engineering Accelerates: Industry Explores New Paths for Technical Synergy
2026-05-14
Synthetic biology-fermentation integration accelerates, driving biomanufacturing. Divoxin offers a reference; applications expand to mRNA vaccines.Challenges: traditional fermentation lags strains; data underutilized; strain construction ignores growth environments.Bridging gaps, collaboration and big data/AI integration are key for biomanufacturing industrialization.
Deep Mastery of Cell Culture Technology: From Mode Selection to Intelligent Control
2026-05-19
This article explores the core of biopharmaceutical upstream processing: cell culture. It systematically describes mammalian cell culture modes (batch, fed-batch, perfusion), details the seed expansion strategy from cell banks to production bioreactors, and highlights how PAT and QbD frameworks enable lean control over cell growth and protein expression. It provides a comprehensive technical perspective on modern cell culture process development and execution.
Building Cell Factories: The Synergistic Evolution of Culture Medium Design and Bioreactor Engineering
2026-01-01
This article focuses on the two pillars of upstream bioprocessing: culture media and bioreactors. It analyzes the logic of chemically defined media development and component optimization while comparing bioreactor types (stirred-tank vs. single-use) regarding design, operation, and scale-up. By explaining how these systems maintain the optimal environment for cell growth, it reveals the path to achieving robustness and economic efficiency in upstream processes.
Uma nova era nos estágios iniciais da fabricação biofarmacêutica: semelhanças entre tecnologias avançadas de inovação contínua, inteligente e modular
2026-01-11
Este artigo examina as tendências e estratégias de ponta no bioprocessamento em estágio inicial. Discute a mudança da produção em batelada para a produção contínua, bem como a forma como a inteligência artificial, a aprendizagem automática e a automação contribuem para o desenvolvimento de processos inteligentes. Também aborda as novas demandas das terapias celulares e genéticas e as perspetivas para a biomanufatura verde, delineando a próxima mudança de paradigma no bioprocessamento upstream.
We use Cookie to improve your online experience. By continuing browsing this website, we assume you agree our use of Cookie.